ArticleEmerging infectious diseases2025

Persistence of Symptoms among Commercially Insured Patients with Coccidioidomycosis, United States, 2017-2023.

Ian Hennessee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.